Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Evanson Jeff Create: Alert

All | News | Filings
Date FiledTypeDescription
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2023 4 Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Sold 267,000 shares @ $1.11, valued at $296.4k
01/19/2023 4 Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Sold 27,162 shares @ $1.31, valued at $35.6k
Sold 33,738 shares @ $1.25, valued at $42.2k
Sold 103,255 shares @ $1.22, valued at $126k
04/04/2022 4 Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $1.44, valued at $144k
12/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2021 4 Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Sold 8,554 shares @ $2.088, valued at $17.9k
02/17/2021 4 Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Sold 56,973 shares @ $2.55, valued at $145.3k
04/21/2020 4 Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 1,207,457 shares @ $0
12/04/2018 3 Evanson Jeff (Chief Commercial Officer) has filed a Form 3 on Outlook Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy